XML 50 R40.htm IDEA: XBRL DOCUMENT
v3.23.3

Third Party Agreements - Additional Information (Details) - USD ($) $ in Millions |  | 9 Months Ended
--- | --- | ---
Jan. 28, 2022 | Sep. 30, 2023
Collaborative Arrangements And Noncollaborative Arrangement Transactions [Line Items] |  |
Research and development in process 1 |  | $ 1.0
License agreement termination description |  | twelve (12) years
Regeneron Pharmaceuticals, Inc. |  |
Collaborative Arrangements And Noncollaborative Arrangement Transactions [Line Items] |  |
Revenue recognized |  | $ 5.0
Exercise Fee Paid | $ 20.0 | 20.0
Licence agreement additional revenue recognised |  | 25.0
Non refundable upfront payment received |  | 25.0
Additional payment for research funding received |  | 20.0
Regeneron Pharmaceuticals, Inc. | Maximum |  |
Collaborative Arrangements And Noncollaborative Arrangement Transactions [Line Items] |  |
Licence agreement additional amount payable of option exercise fees |  | $ 80.0

X
- Definition Exercise fee paid. + References No definition available. + Details
Name: | acet_ExerciseFeePaid
Namespace Prefix: | acet_
Data Type: | xbrli:monetaryItemType
Balance Type: | debit
Period Type: | duration

X
- Definition Additional amount payable of option exercise fees. + References No definition available. + Details
Name: | acet_LicenceAgreementAdditionalAmountPayableOfOptionExerciseFees
Namespace Prefix: | acet_
Data Type: | xbrli:monetaryItemType
Balance Type: | credit
Period Type: | duration

X
- Definition Licence agreement additional revenue recognised. + References No definition available. + Details
Name: | acet_LicenceAgreementAdditionalRevenueRecognised
Namespace Prefix: | acet_
Data Type: | xbrli:monetaryItemType
Balance Type: | credit
Period Type: | duration

X
- Definition Additional payment for research funding received. + References No definition available. + Details
Name: | acet_LicenseAgreementAdditionalPaymentForResearchFundingReceived
Namespace Prefix: | acet_
Data Type: | xbrli:monetaryItemType
Balance Type: | credit
Period Type: | duration

X
- Definition License agreement termination description. + References No definition available. + Details
Name: | acet_LicenseAgreementTerminationDescription
Namespace Prefix: | acet_
Data Type: | xbrli:stringItemType
Balance Type: | na
Period Type: | duration

X
- Definition Non refundable upfront payment received. + References No definition available. + Details
Name: | acet_NonRefundableUpfrontPaymentReceived
Namespace Prefix: | acet_
Data Type: | xbrli:monetaryItemType
Balance Type: | credit
Period Type: | duration

X
- Definition Research and development in process 1 + References No definition available. + Details
Name: | acet_ResearchAndDevelopmentInProcess1
Namespace Prefix: | acet_
Data Type: | xbrli:monetaryItemType
Balance Type: | credit
Period Type: | duration

X
- Definition Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table. + References Reference 1: http://www.xbrl.org/2003/role/disclosureRef -Topic 808 -SubTopic 10 -Name Accounting Standards Codification -Section 50 -Paragraph 1 -Subparagraph (d) -Publisher FASB -URI https://asc.fasb.org//1943274/2147479402/808-10-50-1 + Details
Name: | us-gaap_CollaborativeArrangementsAndNoncollaborativeArrangementTransactionsLineItems
Namespace Prefix: | us-gaap_
Data Type: | xbrli:stringItemType
Balance Type: | na
Period Type: | duration

X
- Definition Amount of revenue recognized that was previously included in balance of obligation to transfer good or service to customer for which consideration from customer has been received or is due. + References Reference 1: http://www.xbrl.org/2003/role/disclosureRef -Topic 606 -SubTopic 10 -Name Accounting Standards Codification -Section 50 -Paragraph 8 -Subparagraph (b) -Publisher FASB -URI https://asc.fasb.org//1943274/2147479806/606-10-50-8 + Details
Name: | us-gaap_ContractWithCustomerLiabilityRevenueRecognized
Namespace Prefix: | us-gaap_
Data Type: | xbrli:monetaryItemType
Balance Type: | credit
Period Type: | duration

X
- Details
Name: | us-gaap_RelatedPartyTransactionsByRelatedPartyAxis=acet_RegeneronPharmaceuticalsIncorporationMember
Namespace Prefix: |
Data Type: | na
Balance Type: |
Period Type: |

X
- Details
Name: | srt_RangeAxis=srt_MaximumMember
Namespace Prefix: |
Data Type: | na
Balance Type: |
Period Type: |